Skip to main content
NBIX logo

Neurocrine Biosciences, Inc.

NBIXNASDAQHealthcareDrug Manufacturers - Specialty & Generic

$136.95Today:- (-)1Y −0.41%

As of Oct 15, 2026 close

Market cap
$14.27B
P/E (TTM)
20.23
Forward P/E
10.04
Dividend yield
-
52-week range
$122.14$186.12
Volume (live)
-
Avg. volume (3M)
1.32M

Neurocrine Biosciences, Inc. (NBIX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Neurocrine Biosciences, Inc. stock.

Analyst Consensus Rating

Investment consensus from 32 professional research analysts

Consensus Rating

Buy
Based on 32 unique analysts
(41 total ratings in last 90 days)
Very High Confidence∞:1 Buy/Sell

Average Price Target

$209.04
+52.64% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest NBIX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

David Amsellem
Piper Sandler
BuyReiterates
$210.00
Tazeen Ahmad
BofA Securities
BuyReiterates
$214.00
Ahan Chakraborty
Zacks Equity Research
HoldInitiates Coverage
-
Brian Abrahams
RBC Capital
BuyMaintains
$187.00
Delma Caiati
Guggenheim
BuyInitiates
$207.00
David Amsellem
Piper Sandler
BuyReiterates
$210.00
Unknown Analyst
Jefferies
BuyMaintains
$220.00
Ashwani Verma
UBS
BuyReiterates
$231.00 → $214.00
Ashwani Verma
UBS
BuyReiterates
$231.00 → $214.00
Jeffrey Walch
Bernstein
BuyMaintains
$218.00
Jeffrey Walch
Bernstein
BuyMaintains
$218.00
Brian Abrahams
RBC Capital
BuyMaintains
$198.00 → $187.00
Unknown Analyst
CCB Intl.
BuyInitiates
$188.00
Sean Laaman
Morgan Stanley
HoldReiterates
$182.00 → $183.00
Yigal Nochomovitz
Citi
BuyMaintains
$249.00 → $253.00
Yigal Nochomovitz
Citi
BuyMaintains
$249.00 → $253.00
Sundeep Ganoria
Zacks Equity Research
HoldInitiates Coverage
-
Evan Seigerman
BMO Capital
HoldMaintains
$190.00
Cory Kasimov
Evercore ISI Group
BuyMaintains
$210.00 → $215.00
David Hoang
Deutsche Bank
HoldInitiates Coverage
$190.00 → $165.00
Kanishka Das
Zacks Equity Research
BuyInitiates Coverage
-
Anupam Rama
JP Morgan
BuyMaintains
$185.00 → $217.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Sumant Kulkarni
Canaccord Genuity
BuyReiterates
$200.00 → $210.00
Laura Chico
Wedbush
BuyMaintains
$185.00 → $194.00
Danielle Brill
Truist
BuyMaintains
$213.00
Paul Matteis
Stifel Nicolaus
BuyMaintains
$188.00 → $215.00
Yatin Suneja
Guggenheim
BuyMaintains
$200.00 → $222.00
Andrew Fein
HC Wainwright
BuyMaintains
$215.00
Myles Minter
William Blair
BuyReiterates
-
David Amsellem
Piper Sandler
BuyReiterates
$207.00 → $210.00
Phil Nadeau
TD Cowen
BuyInitiates Coverage
$200.00 → $220.00
Ashwani Verma
UBS
BuyMaintains
$208.00 → $231.00
Mohit Bansal
Wells Fargo
BuyInitiates Coverage
$200.00
Brian Skorney
Baird
BuyMaintains
$186.00 → $225.00
Jay Olson
Oppenheimer
BuyMaintains
$230.00
Ami Fadia
Needham
BuyInitiates Coverage
$200.00 → $204.00
Joshua Schimmer
Cantor Fitzgerald
BuyInitiates Coverage
$210.00 → $215.00
Akash Tewari
Jefferies
BuyMaintains
$200.00
Tazeen Ahmad
BofA Securities
BuyReiterates
$199.00 → $214.00
Brian Abrahams
RBC Capital
BuyInitiates Coverage
$195.00 → $198.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 9, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for NBIX?

The analyst consensus rating for NBIX is Buy, based on the latest ratings from 32 analysts over the last 90 days.

What is the average price target for NBIX?

The average 12-month price target for NBIX is $209.04, representing an upside of 52.6% from the Oct 15, 2026 close of $136.95.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.